![[HTML version]](/e/graphics/htmlborder.gif)
![[PDF version]](/e/graphics/pdfborder.gif)
![[CIF]](/e/graphics/cifborder.gif)
![[3d view]](/e/graphics/3dviewborder.gif)
![[Structure Factors]](/e/graphics/structurefactorsborder.gif)
![[CIF check Report]](/e/graphics/checkcifborder.gif)
![[Issue contents]](/e/graphics/issuecontentsborder.gif)
![[Buy article online]](/logos/buy.gif)
![[Contents scheme]](wn6369contents.gif)
Acta Cryst. (2005). E61, m1548-m1549 [ doi:10.1107/S1600536805021677 ]
![[mu]](/logos/entities/mu_rmgif.gif)
-2,4-dihydroxyacetophenone salicylhydrazidato)bis[pyridinezinc(II)] dimethylformamide disolvateAbstract: The tridentate Schiff base ligand 2,4-dihydroxyacetophenone salicylhydrazide, derived from the condensation of 2,4-dihydroxyacetophenone and salicylhydrazide, in the presence of pyridine and N,N'-dimethylformamide, forms a dinuclear distorted square-pyramidal Zn complex with Zn(OAc)2·2H2O, viz. [Zn2(C15H12N2O4)2(C5H5N)2]·2C3H7NO. The complex is centrosymmetric and the two Zn atoms are bridged by two phenolate O atoms.
Online 13 July 2005
Copyright © International Union of Crystallography
IUCr Webmaster